#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	659	3142	16S	1529	1529	99.87	16S.l15.c4.ctg.1	2519	370.7	0	.	n	.	0	A69G	SNP	69	69	A	563	563	G	445	G,A	279,100	.	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	659	3142	16S	1529	1529	99.87	16S.l15.c4.ctg.1	2519	370.7	0	.	n	.	0	C1450T	SNP	1450	1450	C	1944	1944	T	486	T	402	.	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	659	3142	16S	1529	1529	99.87	16S.l15.c4.ctg.1	2519	370.7	1	SNP	n	C1184T	0	.	.	1184	1184	C	1678	1678	C	490	C	390	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	5038	23S	2890	2890	99.93	23S.l6.c4.ctg.1	3740	402.4	0	.	n	.	0	G1337A	SNP	1337	1337	G	1795	1795	A	416	A	342	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	5038	23S	2890	2890	99.93	23S.l6.c4.ctg.1	3740	402.4	0	.	n	.	0	T1971C	SNP	1971	1971	T	2429	2429	C	488	C	398	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	5038	23S	2890	2890	99.93	23S.l6.c4.ctg.1	3740	402.4	1	SNP	n	A2045G	0	.	.	2045	2045	A	2503	2503	A	506	A,C	394,1	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	5038	23S	2890	2890	99.93	23S.l6.c4.ctg.1	3740	402.4	1	SNP	n	C2597T	0	.	.	2597	2597	C	3055	3055	C	452	C,A,T	358,2,1	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
folP.WHO_N_01367c	folP.WHO_N_01367c	1	1	539	478	folP	852	852	99.88	folP.l15.c4.ctg.1	1841	77.1	0	.	p	.	0	E151K	NONSYN	451	453	GAA	942	944	AAA	95;96;95	A;A;A	80;78;77	.	.
folP.WHO_N_01367c	folP.WHO_N_01367c	1	1	539	478	folP	852	852	99.88	folP.l15.c4.ctg.1	1841	77.1	1	SNP	p	R228S	1	.	.	682	684	AGC	1173	1175	AGC	86;86;86	A;G;C	72;70;70	folP.WHO_N_01367c:1:1:R228S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	1080	gyrA	2751	2751	100.0	gyrA.l15.c4.ctg.1	3602	89.6	1	SNP	p	S91F	0	.	.	271	273	TCC	703	705	TCC	78;79;79	T;C;C	61;62;63	gyrA.WHO_F_00668c:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	1080	gyrA	2751	2751	100.0	gyrA.l15.c4.ctg.1	3602	89.6	1	SNP	p	D95G	0	.	.	283	285	GAC	715	717	GAC	79;79;79	G;A,C;C	64;60,1;62	gyrA.WHO_F_00668c:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	1080	gyrA	2751	2751	100.0	gyrA.l15.c4.ctg.1	3602	89.6	1	SNP	p	D95N	0	.	.	283	285	GAC	715	717	GAC	79;79;79	G;A,C;C	64;60,1;62	gyrA.WHO_F_00668c:1:1:D95N:gyrA.95N:Resistance to fluoroquinolones	.
mtrR.WHO_Y_01506	mtrR.WHO_Y_01506	1	1	27	418	mtrR	633	633	100.0	mtrR.l15.c4.ctg.1	1611	77.3	1	SNP	p	G45D	0	.	.	133	135	GGC	480	482	GGC	107;107;107	G;G;C,T	86;87;88,1	mtrR.WHO_Y_01506:1:1:G45D:mtrR.45D:Increased efflux of antimicrobials, e.g. macrolides and b-lactam antimicrobials, that are substrates of the MtrCDE efflux pump	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	531	204	mtrR_promoter	250	250	99.6	mtrR_promoter.l15.c4.ctg.1	1396	43.8	0	.	n	.	0	A197.	DEL	197	197	A	745	745	A	104	A	82	.	.
parC.WHO_M_00204c	parC.WHO_M_00204c	1	1	27	980	parC	2304	2304	99.91	parC.l15.c4.ctg.1	3130	93.6	1	SNP	p	D86N	0	.	.	256	258	GAC	631	633	GAC	114;112;111	G,T;A;C	93,1;89;93	parC.WHO_M_00204c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_M_00204c	parC.WHO_M_00204c	1	1	27	980	parC	2304	2304	99.91	parC.l15.c4.ctg.1	3130	93.6	1	SNP	p	S87W	0	.	.	259	261	AGT	634	636	AGT	111;111;111	A;G;T	91;92;88	parC.WHO_M_00204c:1:1:S87W:parC.87W:Resistance to fluoroquinolones	.
parC.WHO_M_00204c	parC.WHO_M_00204c	1	1	27	980	parC	2304	2304	99.91	parC.l15.c4.ctg.1	3130	93.6	1	SNP	p	S87R	0	.	.	259	261	AGT	634	636	AGT	111;111;111	A;G;T	91;92;88	parC.WHO_M_00204c:1:1:S87R:parC.87R:Resistance to fluoroquinolones	.
parC.WHO_M_00204c	parC.WHO_M_00204c	1	1	27	980	parC	2304	2304	99.91	parC.l15.c4.ctg.1	3130	93.6	1	SNP	p	S87I	0	.	.	259	261	AGT	634	636	AGT	111;111;111	A;G;T	91;92;88	parC.WHO_M_00204c:1:1:S87I:parC.87I:Resistance to fluoroquinolones	.
parC.WHO_M_00204c	parC.WHO_M_00204c	1	1	27	980	parC	2304	2304	99.91	parC.l15.c4.ctg.1	3130	93.6	1	SNP	p	S88P	0	.	.	262	264	TCC	637	639	TCC	110;111;112	T,C,A;C;C	90,1,1;94;93	parC.WHO_M_00204c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	27	818	parE	1986	1986	100.0	parE.l15.c4.ctg.1	2965	82.6	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1713	1715	GGC	110;111;111	G,T;G;C	90,1;91;89	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.9.001	penA.9.001	1	1	27	774	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2649	87.3	1	SNP	p	A311V	0	.	.	931	933	GCA	1333	1335	GCA	115;113;113	G;C;A,C	100;99;101,1	penA.9.001:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	27	774	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2649	87.3	1	SNP	p	I312M	0	.	.	934	936	ATC	1336	1338	ATC	114;113;112	A;T;C,A	102;100;98,1	penA.9.001:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	27	774	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2649	87.3	1	SNP	p	V316T	0	.	.	946	948	GTG	1348	1350	GTG	117;117;117	G,A;T;G	105,1;101;102	penA.9.001:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	27	774	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2649	87.3	1	SNP	p	V316P	0	.	.	946	948	GTG	1348	1350	GTG	117;117;117	G,A;T;G	105,1;101;102	penA.9.001:1:1:V316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	27	774	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2649	87.3	1	SNP	p	T484S	0	.	.	1450	1452	ACC	1852	1854	ACC	83;84;84	A,C;C;C	64,1;67;66	penA.9.001:1:1:T484S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	27	774	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2649	87.3	1	SNP	p	A502V	0	.	.	1504	1506	GCG	1906	1908	GCG	78;78;78	G;C;G	65;62;64	penA.9.001:1:1:A502V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	27	774	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2649	87.3	1	SNP	p	A502P	0	.	.	1504	1506	GCG	1906	1908	GCG	78;78;78	G;C;G	65;62;64	penA.9.001:1:1:A502P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	27	774	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2649	87.3	1	SNP	p	G543S	0	.	.	1627	1629	GGC	2029	2031	GGC	78;78;78	G;G;C,T	60;61;60,1	penA.9.001:1:1:G543S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	27	774	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2649	87.3	1	SNP	p	G546S	0	.	.	1636	1638	GGC	2038	2040	GGC	78;78;78	G;G;C	60;61;62	penA.9.001:1:1:G546S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	27	774	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2649	87.3	1	SNP	p	L552S	0	.	.	1654	1656	CTG	2056	2058	CTG	75;75;76	C,T;T,C;G	58,1;57,1;56	penA.9.001:1:1:L552S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_G_00106	ponA.WHO_G_00106	1	1	27	1140	ponA	2397	2397	100.0	ponA.l6.c17.ctg.1	3734	91.2	1	SNP	p	L421P	1	.	.	1261	1263	CCG	1836	1838	CCG	90;90;90	C;C;G	70;71;71	ponA.WHO_G_00106:1:1:L421P:ponA.421P:High-level chromosomally-mediated penicillin resistance	.
porA.NCCP11945	porA.NCCP11945	1	0	531	480	porA	1146	1146	99.65	porA.l15.c4.ctg.1	2168	66.2	0	.	p	.	0	M83fs	FSHIFT	247	247	A	714	714	C	64	C	51	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	608	porB1b	1047	1047	99.24	porB1b.l6.c4.ctg.1	1915	94.7	0	.	p	.	0	N38E	NONSYN	112	114	AAT	573	575	GAA	112;112;112	G;A;A	92;91;92	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	608	porB1b	1047	1047	99.24	porB1b.l6.c4.ctg.1	1915	94.7	0	.	p	.	0	N134D	NONSYN	400	402	AAT	861	863	GAT	116;115;116	G;A;T	91;89;89	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	608	porB1b	1047	1047	99.24	porB1b.l6.c4.ctg.1	1915	94.7	0	.	p	.	0	P175S	NONSYN	523	525	CCA	984	986	TCA	128;128;129	T;C;A	100;102;102	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	608	porB1b	1047	1047	99.24	porB1b.l6.c4.ctg.1	1915	94.7	0	.	p	.	0	A218V	NONSYN	652	654	GCC	1113	1115	GTC	148;147;147	G;T,C;C	105;106,1;107	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	608	porB1b	1047	1047	99.24	porB1b.l6.c4.ctg.1	1915	94.7	0	.	p	.	0	F222S	NONSYN	664	666	TTT	1125	1127	TCT	144;145;145	T;C,T;T	110;111,1;112	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	608	porB1b	1047	1047	99.24	porB1b.l6.c4.ctg.1	1915	94.7	0	.	p	.	0	E328A	NONSYN	982	984	GAA	1443	1445	GCA	143;144;145	G;C;A	109;110;110	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	608	porB1b	1047	1047	99.24	porB1b.l6.c4.ctg.1	1915	94.7	1	SNP	p	G120K	1	.	.	358	360	AAG	819	821	AAG	108;108;108	A;A;G,A	84;83;84,1	porB1b.WHO_V_02265c:1:1:G120K:porB1b.120K:G101K. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	608	porB1b	1047	1047	99.24	porB1b.l6.c4.ctg.1	1915	94.7	1	SNP	p	A121D	1	.	.	361	363	GAC	822	824	GAC	109;108;108	G;A;C,T	89;86;82,1	porB1b.WHO_V_02265c:1:1:A121D:porB1b.121D:A102D. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	608	porB1b	1047	1047	99.24	porB1b.l6.c4.ctg.1	1915	94.7	1	SNP	p	D121N	0	.	.	361	363	GAC	822	824	GAC	109;108;108	G;A;C,T	89;86;82,1	porB1b.WHO_V_02265c:1:1:D121N:porB1b.121N:A102N. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
rpoB.WHO_F_02153c	rpoB.WHO_F_02153c	1	1	539	2182	rpoB	4179	4179	99.98	rpoB.l6.c4.ctg.1	5090	128.2	1	SNP	p	H553N	1	H553N	NONSYN	1657	1659	CAT	2167	2169	AAT	112;111;111	A;A,G;T,G	97;92,1;89,2	rpoB.WHO_F_02153c:1:1:H553N:rpoB.553N:H552N. High-level resistance to Rifampicin	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	342	rpsJ	312	312	100.0	rpsJ.l15.c4.ctg.1	1430	71.8	1	SNP	p	V57M	1	.	.	169	171	ATG	749	751	ATG	130;130;130	A,G;T;G	111,1;109;110	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
